Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 6, 2001, Pages 627-632

  Banov, Charles H ^a   Howland, William C ^b   Lumry, William R ^c  

^a Allerg and Asthma Centers of C   (United States)

^b HealthQuest Therapy/Res Inst Inc   (United States)

^c Allergy And Asthma Research Associates Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT;

EID: 0034973009     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62290-9     Document Type: Article

References (18)

1. Budesonide: An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis
2. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI
3. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
4. Rapid onset of control with budesonide Turbuhaler in patients with mild to moderate asthma
5. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: A double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma
6. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
7. The effect of prescribed daily dose frequency on patient medication compliance
8. Nonadherence in asthmatic patients: Is there a solution to the problem?
9. Measuring compliance with inhaled medication in asthma
10. Compliance with inhaled therapy and morbidity from asthma
11. Compliance and outcomes in patients with asthma
12. Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthma
13. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
14. Once daily budesonide turbohaler compared with placebo as initial prophylactic therapy for asthma
15. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma
16. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide
17. Once-daily versus twice-daily dosing of theophylline. A decision analysis approach to evaluating theophylline blood levels and compliance